Amanote Research

Amanote Research

    RegisterSign In

Role of Rivaroxaban in the Management of Atrial Fibrillation: Insights From Clinical Practice

Vascular Health and Risk Management
doi 10.2147/vhrm.s134394
Full Text
Open PDF
Abstract

Available in full text

Date

January 1, 2018

Authors
Kavitha VimalesvaranSeth DockrillDiana A Gorog
Publisher

Informa UK Limited


Related search

Rivaroxaban in Clinical Practice for Atrial Fibrillation With Special Reference to Prothrombin Time

Circulation Journal
MedicineCardiovascular MedicineCardiology
2014English

Rivaroxaban Versus Warfarin in Nonvalvular Atrial Fibrillation

Yearbook of Cardiology
2012English

Health Economic Evaluation of Rivaroxaban in Elective Cardioversion of Atrial Fibrillation

European Journal of Health Economics
Health PolicyEconomicsEconometricsFinance
2017English

Heart Failure and Atrial Fibrillation: From Basic Science to Clinical Practice

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2015English

ABC of Atrial Fibrillation: ATRIAL FIBRILLATION IN GENERAL AND HOSPITAL PRACTICE

BMJ
1996English

Management of Atrial Fibrillation

2014English

Management of Atrial Fibrillation

The Lancet
Medicine
2007English

The Role of Superior Vena Cava Isolation in the Management of Atrial Fibrillation

Journal of Innovations in Cardiac Rhythm Management
2017English

Management of Atrial Fibrillation in Diabetes

Practical Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy